David Dilworth

Company: BlueRock Therapeutics

Job title: Senior Scientist, Assay Development

Seminars:

Early-Stage Potency Assay Development for Regenerative Cell Therapies 12:00 pm

• Leveraging advanced technologies to increase understanding  of drug product mechanism of action towards establishing a  meaningful matrix of functional assays • Developing phase appropriate early-stage potency assays  for the characterization of pluripotent stem cell-derived  regenerative medicines  • Moving from a characterization matrix to a suitable assay for drug product release and stability testingRead more

day: Conference Day One - Track B - AM